Brief: Nurexone Secures Eureka Grant For Collaborative Partnership To Expand To Chronic Spinal Cord Injury Therapy
11/10/2023 13:47
Oct 11 (Reuters) - Nurexone Biologic Inc NRX.V :
* NUREXONE SECURES EUREKA GRANT FOR COLLABORATIVE
PARTNERSHIP TO
EXPAND TO CHRONIC SPINAL CORD INJURY THERAPY
Source text for Eikon: ID:nGNX5FQ42Q
Further company coverage: NRX.V
((Reuters.Briefs@thomsonreuters.com))
Recent news on Nurexone Biologic
See all newsBrief: Nurexone Announces Binding MoU With Made Scientific For U.S. Gmp Manufacturing And Commercial Supply Partnership
Brief: Corporate Updates – Nurexone Appoints Mr. David Stolick To The Board Of Directors
Brief: Exo-Top, Nurexone’S Wholly Owned U.S. Subsidiary, Enters Into Binding MoU For Naïve Exosome Distribution In Mexico
Brief: Nurexone Biologic’S U.S. Subsidiary Exo-Top And Florida-Based Bioxtek Sign Strategic Loi For Exosome Manufacturing And Commercialization
Brief: Nurexone Strengthens U.S. Manufacturing Strategy Through Exo-Top Sublicense Agreement